Comparison of effectiveness of caffeine with Aminophylline in treatment of prematurity apnea in preterm
Early Phase 1
- Conditions
- Apnea of Prematurity.Respiratory disorder, unspecified
- Registration Number
- IRCT20181110041605N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Neonate with apnea of prematurity that was GA <34 WEEK
Exclusion Criteria
Neonate with apnea of prematurity that not due to sepsis ,heart disease , hypoglycemi ,was not intuba
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence of apnea. Timepoint: 72 hours after treatment. Method of measurement: Analysis of recurrence of apnea in 72 hours after treatment.
- Secondary Outcome Measures
Name Time Method Complication of drugs and recurrence of apnea. Timepoint: 72 hours after treatment. Method of measurement: Analysis of complication of drugs in 72 hours after treatment.